Exemestane vs Winstrol
FDA Approved vs Well Studied
avoid Mechanism-based · 64% Both Exemestane and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Exemestane Winstrol
Weight 296.40 Da 328.49 Da
Half-life ~24 hours ~9 hours (oral), ~24 hours (injectable)
Type Steroidal aromatase inhibitor (irreversible, suicide inhibitor) 17-alpha-alkylated anabolic-androgenic steroid (C21H32N2O)
Key Benefits
Exemestane
01 Irreversible aromatase inactivation eliminates estrogen rebound upon discontinuation
02 Steroidal structure with mild androgenic activity may offset some low-estrogen side effects
03 Potent estrogen suppression (85-95% reduction in estradiol at full dose)
04 Compatible with tamoxifen (unlike anastrozole, no pharmacokinetic interference)
05 Prevents gynecomastia during testosterone or aromatizable steroid cycles
06 Reduces estrogen-driven water retention, bloating, and blood pressure elevation
07 Oral dosing with once-daily or less frequent administration for cycle support
Winstrol
01 Produces a dry, hard, and vascular appearance without water retention
02 Significant strength increases without proportional weight gain, favored in weight-class sports
03 Does not aromatize to estrogen, eliminating gynecomastia and bloating concerns
04 Potent suppression of SHBG, increasing free testosterone and enhancing the effectiveness of stacked compounds
05 Available in both oral and injectable formulations
06 High anabolic-to-androgenic ratio (320:30) relative to methyltestosterone
07 FDA-approved for hereditary angioedema prophylaxis
08 Enhances vascularity and muscle definition during caloric deficit
Dosing Protocols
Exemestane
12.5mg EOD or 25mg E3D (estrogen management) / Every other day to every 3 days (cycle support); daily (breast cancer)
Winstrol
25-50 mg/day (oral), 50 mg EOD (injectable) / Daily (oral) or every other day (injectable)
Performance - Standard Injectable 50 mg every other day Every other day (EOD)
Side Effects
Exemestane
Joint pain and stiffness (generally less severe than with anastrozole due to mild androgenic activity)
Fatigue and general malaise
Hot flashes or flushing
Mood changes (irritability, flat affect, low mood)
Headache
Increased sweating
Winstrol
Severe HDL cholesterol suppression (winstrol is among the worst oral steroids for lipid damage)
Significant LDL cholesterol elevation
Joint dryness and pain, particularly in knees, shoulders, and elbows (notorious side effect)
Hepatic stress with elevated liver enzymes (ALT/AST)
Suppression of endogenous testosterone production
Hair loss and accelerated male pattern baldness (DHT derivative, particularly harsh on hairline)
Acne and oily skin
Tendon and ligament stress due to rapid strength gains combined with reduced joint lubrication
Dry, painful shin splints during cardiovascular exercise
Contraindications
Known hypersensitivity to exemestane or any excipients
Premenopausal women (not indicated and potentially harmful to reproductive function)
Pregnancy or breastfeeding (teratogenic risk)
Severe hepatic impairment
Pre-existing severe osteoporosis or high fracture risk
Concurrent use with other aromatase inhibitors (anastrozole, letrozole)
Known or suspected prostate cancer
Breast cancer in males
Breast cancer with hypercalcemia in females
Pregnancy (Category X - known to cause fetal harm)
Severe hepatic dysfunction or active liver disease
Nephrosis or nephrotic phase of nephritis
Pre-existing severe cardiovascular disease or dyslipidemia
Hypersensitivity to stanozolol or any formulation component
Research Evidence
Exemestane Winstrol
Status FDA Approved Well Studied
References 5 studies 5 studies
Latest — June 2023
FDA Approved Yes Yes
More comparisons: Testosterone
This comparison is for educational and research purposes only. Consult a healthcare professional before use.